*Wallace H. Coulter Department of Biomedical Engineering at Georgia Tech and Emory University
‡School of Chemical and Biomolecular Engineering, Georgia Institute of Technology
†Department of Anesthesiology, Center for Pain Medicine, Emory University, Atlanta, GA. Mark R. Prausnitz is the Emerson-Lewis Faculty Fellow
Conflict of Interest: Harvinder S. Gill and Mark R. Prausnitz are coinventors on a microneedle-based patent that has been licensed to a company. In addition, Mark R. Prausnitz is a coinventor on other patents and is a consultant and advisor to companies working on microneedles. Although there are currently no products based on microneedles, and this study does not involve any commercial products, the results of this research could indirectly influence the success of possible future commercial activities in which these 2 authors have an interest.
Supported in part by the National Institutes of Health. NIH grants 1U01AI074579-01 and 1R01EB006369-01A1.
Reprints: Mark R. Prausnitz, PhD, School of Chemical and Biomolecular Engineering, Georgia Institute of Technology, 311 Ferst Drive, Atlanta, GA 30332-0100 (e-mail: [email protected]).
Received for publication August 15, 2007; revised January 2, 2008; accepted January 6, 2008
This work took place in the Center for Drug Design, Development and Delivery and the Institute for Bioengineering and Bioscience at the Georgia Institute of Technology.